Category:
Active Pharmaceutical Ingredients
CAS NO:
/
Standard:
In-house Standards,
Please contact us for more details
This portfolio comprises critical pharmaceutical APIs including Mometasone Furoate (CAS 53219-48-0), Capecitabine (CAS 154361-50-9), and Cyclophosphamide (CAS 50-18-0). Synthesis involves advanced organic chemistry with strict GMP compliance. Key compounds like Aripiprazole, Brivaracetam, Dapoxetine, and Levetiracetam are manufactured via high-purity crystallization processes.
Strict storage at controlled room temperature is mandatory to prevent degradation. Handling requires PPE due to potential cytotoxicity, especially for Cyclophosphamide. Clinical use must adhere to prescribed dosages to avoid severe adverse reactions.